Posturography as a biomarker of intravenous immunoglobulin efficacy in chronic inflammatory demyelinating polyradiculoneuropathy
- 12 August 2021
- journal article
- research article
- Published by Wiley in Muscle & Nerve
- Vol. 65 (1) , 43-50
Abstract
Introduction/Aims: Imbalance is a common feature of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Intravenous immunoglobulin (IVIg) exerts clinical benefit in CIDP, including improving balance, although objective markers of efficacy are lacking. Posturography is an established objective marker of balance; therefore, this study aimed to determine the utility of posturography as an objective marker of treatment efficacy in CIDP.Methods: Posturography was performed on 18 CIDP patients, established on IVIg infusions, and results were compared to age‐matched healthy controls. CIDP patients were assessed just prior to IVIg infusion and at the mid‐point of the cycle. Center of pressure (CoP) was measured and the total path traveled by CoP (Sway Path, SP) was calculated for five different conditions: feet placed in parallel 16 cm apart at the medial border with eyes open (16cmEO) and eyes closed (16cmEC); medial borders of the feet touching with eyes open (0cmEO) and eyes closed (0cmEC); and tandem stance.Results: The sway path (SP) was significantly increased in CIDP patients (mean SP 1191 ± 104 mm) when compared to healthy controls (mean SP 724 ± 26 mm, P < .001). The increase was most prominent during eyes closed and tandem stance conditions. Treatment with IVIg significantly reduced SP when assessing 0cmEC (1759 ± 324 mm vs. 1081 ± 134 mm, P = .019) and tandem stance (1775 ± 290 mm vs. 1152 ± 113 mm, P = .027).Discussion: Posturography detected significant improvements in balance following IVIg in CIDP patients established on maintenance therapy. As such, posturography may be considered an objective marker of treatment response in clinical management and therapeutic trials.Keywords
This publication has 25 references indexed in Scilit:
- Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studiesJournal of the Peripheral Nervous System, 2019
- A comparison of balance control during stance and gait in patients with inflammatory and non-inflammatory polyneuropathyPLOS ONE, 2018
- Differentiating lower motor neuron syndromesJournal of Neurology, Neurosurgery & Psychiatry, 2016
- Two years’ long-term follow up in chronic inflammatory demyelinating polyradiculoneuropathy: efficacy of intravenous immunoglobulin treatmentTherapeutic Advances in Neurological Disorders, 2016
- Stance Postural Strategies in Patients with Chronic Inflammatory Demyelinating PolyradiculoneuropathyPLOS ONE, 2016
- Modulatory Effects on Axonal Function After Intravenous Immunoglobulin Therapy in Chronic Inflammatory Demyelinating PolyneuropathyArchives of Neurology, 2011
- European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society — First RevisionEuropean Journal of Neurology, 2010
- Fast Computational Analysis of Sway Area Using Center of Pressure Data in Normal Children and Children with Cerebral PalsyAmerican Journal of Biomedical Sciences, 2009
- Health-related quality-of-life improvements in CIDP with immune globulin IV 10%Neurology, 2009
- Functional health status of patients with chronic inflammatory neuropathiesJournal of the Peripheral Nervous System, 2005